These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 14740606)

  • 41. Patent infringement. Generic HIV drugmaker's patent claim is time-barred.
    AIDS Policy Law; 2003 Aug; 18(16):6. PubMed ID: 14626916
    [No Abstract]   [Full Text] [Related]  

  • 42. BMS-232632 (Novartis/Bristol-Myers Squibb).
    Witherell G
    Curr Opin Investig Drugs; 2001 Mar; 2(3):340-7. PubMed ID: 11575702
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Thailand's head-on approach.
    Ismartono Y
    AIDS Watch; 1989; (8):4-5. PubMed ID: 12315984
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Changes to India's patent law: integrated approach is needed.
    Barker R
    BMJ; 2005 Apr; 330(7498):1025. PubMed ID: 15860837
    [No Abstract]   [Full Text] [Related]  

  • 45. Companies reduce prices for HIV drugs in developing countries.
    Gottlieb S
    Bull World Health Organ; 2000; 78(6):862. PubMed ID: 10916926
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Thailand's do-it-yourself therapy.
    Cohen J
    Science; 2003 Sep; 301(5640):1662. PubMed ID: 14500957
    [No Abstract]   [Full Text] [Related]  

  • 47. An overview of a recent court challenge to the protection of biomarkers as intellectual property.
    Hall SC; Tromp JM; Jortani SA
    Clin Chim Acta; 2011 May; 412(11-12):802-5. PubMed ID: 21315704
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Canadian court upholds Glaxo's patent on AZT.
    Elliott R
    Can HIV AIDS Policy Law Rev; 2001; 6(1-2):53-7. PubMed ID: 11837029
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mixed WTO ruling on generic drug development.
    Elliott R
    Can HIV AIDS Policy Law Newsl; 2000; 5(2-3):38-42, 40-4. PubMed ID: 11833195
    [TBL] [Abstract][Full Text] [Related]  

  • 50. OX40 agonists for cancer treatment: a patent review.
    Cebada J; Perez-Santos M; Bandala C; Lara-Padilla E; Herrera-Camacho I; Rosas-Murrieta NH; Millán-Pérez Peña L; Monjaraz E; Flores A; Anaya-Ruiz M
    Expert Opin Ther Pat; 2021 Jan; 31(1):81-90. PubMed ID: 32945223
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents: the recommendations of the Thai AIDS Society (TAS) 2008.
    Sungkanuparph S; Anekthananon T; Hiransuthikul N; Bowonwatanuwong C; Supparatpinyo K; Mootsikapun P; Chetchotisakd P; Kiertiburanakul S; Tansuphaswadikul S; Buppanharun W; Manosuthi W; Techasathit W; Ratanasuwan W; Tantisiriwat W; Suwanagool S; Leechawengwongs M; Ruxrungtham K;
    J Med Assoc Thai; 2008 Dec; 91(12):1925-35. PubMed ID: 19133532
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expanding community through ARV provision in Thailand.
    Lyttleton C; Beesey A; Sitthikriengkrai M
    AIDS Care; 2007; 19 Suppl 1():S44-53. PubMed ID: 17364387
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evolution of medical services for HIV/AIDS in Thailand.
    Kunanusont C; Phoolcharoen W; Bodaramik Y
    J Med Assoc Thai; 1999 May; 82(5):425-34. PubMed ID: 10443091
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Essential AIDS medications in India.
    Thomas J
    Issues Med Ethics; 2000; 8(2):62. PubMed ID: 16323350
    [No Abstract]   [Full Text] [Related]  

  • 55. India: Court upholds patent law denying patents for slightly modified versions of existing drugs.
    Swamy M
    HIV AIDS Policy Law Rev; 2007 Dec; 12(2-3):50-1. PubMed ID: 18459215
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HIV/AIDS care and treatment in three provinces in northern Thailand before the national scale-up of highly-active antiretroviral therapy.
    Thanprasertsuk S; Lertpiriyasuwat C; Leusaree T; Sirinirund P; Sumanapan S; Chariyalertsak C; Simmons N; Ellerbrock TV; Siraprapasiri T; Yachompoo C; Panputtanakul S; Virapat P; Supakalin P; Srithaniviboonchai K; Mock P; Supawitkul S; Tappero JW; Levine WC
    Southeast Asian J Trop Med Public Health; 2006 Jan; 37(1):83-9. PubMed ID: 16771217
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations.
    Pinheiro Edos S; Antunes OA; Fortunak JM
    Antiviral Res; 2008 Sep; 79(3):143-65. PubMed ID: 18571246
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Access to essential medicines: a Hobbesian social contract approach.
    Ashcroft RE
    Dev World Bioeth; 2005 May; 5(2):121-41. PubMed ID: 15842722
    [TBL] [Abstract][Full Text] [Related]  

  • 59. After the forest. AIDs as ecological collapse in Thailand.
    Usher AD
    Dev Dialogue; 1992; (1-2):13-49. PubMed ID: 12286883
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Balancing public health, trade and intellectual monopoly privileges: recent Australian IP legislation and the TPPA.
    Vines T; Crow K; Faunce T
    J Law Med; 2012 Dec; 20(2):280-94. PubMed ID: 23431847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.